Cadila Healthcare up 1% on USFDA final approval for Allopurinol tablets News News / News 6 years ago 476 Views comments Zydus Cadila has received final approval from the USFDA to market Allopurinol Tablets USP, 100 mg and 300 mg. Read more
News Sell PFC, Tata Motors, State Bank of India; buy IIFL Holdings, SCI: Ashwani Gujral News / News - 6 years ago
Comments